Finasteride Timeline: What to Expect Month by Month

A realistic finasteride timeline rarely matches what most patients expect at the start. The medication begins working at the biochemical level within days, but visible change at the scalp is bounded by how slowly hair actually grows. Healthy scalp hair grows around half an inch per month, which means the new, healthier hairs that finasteride helps re-engage need months of growing time before they show up to the eye. Understanding this lag, and what tends to happen in each window, makes the early months less disorienting and the later months more meaningful.

This page walks through what clinical trials and longitudinal patient experience suggest you may see from month 1 through year 2 on finasteride. The pattern is not universal, and individual variation is significant, but the broad arc is consistent enough that we can describe it with confidence.

Month 1: Internal change, no visible difference

In the first 30 days of finasteride therapy, the most important changes happen out of sight. Within 24 hours of the first dose, scalp DHT begins to drop. By the end of the first week, serum DHT has fallen by roughly 65 to 70 percent and reaches a new steady state. This is the biochemical foundation for everything that follows.

What you will notice at the scalp during this window is, generally, nothing. Your hair count, density, and texture should look essentially unchanged from the day you started. Patients who expect a visible difference at the one-month mark are usually disappointed, but this is consistent with how hair grows, not a sign that the medication is failing.

Some patients experience early scalp sensations (a mild tingling, dryness, or oiliness change), though these are not well-characterized in the clinical literature and are inconsistent across patients.

Months 2 to 4: The shedding phase

This window is the most psychologically difficult for many patients on finasteride. Somewhere between week 2 and month 4, a meaningful subset of patients begin to notice increased shedding. This is the well-described "dread shed" phenomenon. We cover the biology and management of it in detail in Finasteride Shedding, but in summary: as DHT-suppressed follicles exit telogen and enter a new anagen phase, the new hairs push out the old miniaturized ones, producing a visible spike in daily hair loss.

The shed typically lasts 4 to 8 weeks from onset. For some patients, it is barely noticeable; for others, the daily shed count can briefly double or triple before settling. The hairs being shed during this phase are usually the fine, miniaturized hairs that were on their way out anyway.

If you do not experience a visible shed during this window, that is also normal. Roughly half of patients on finasteride do not report a clear shed phase, and the absence does not indicate poor response.

The other thing worth noting in this window is that overall density may temporarily look slightly worse than baseline. This can be unsettling, but it is generally temporary and reflects the transition between old and new anagen hairs rather than disease progression. The biology of why this happens is similar to what we describe in Why Hair Sheds When You Start Treatment.

Months 4 to 6: Stabilization

By month 4, shedding has typically resolved or is in clear decline. The next 6 to 8 weeks tend to be a stabilization phase, where overall density looks similar to baseline (or slightly thinner if a shed occurred), and the cycle re-engagement is happening at the follicle level but is not yet producing visible regrowth.

This is often the quietest window of treatment, and patients can lose motivation here because nothing dramatic appears to be changing. From the follicle's perspective, however, this is exactly when the new anagen hairs are growing in length but are still too short to contribute meaningfully to surface density.

Two things are worth doing during this window:

• Continue tracking with monthly photos. Subtle density changes are extremely difficult to assess in real time. Side-by-side photos at month 2 versus month 6 often show a difference that the mirror does not.
• Resist the urge to change protocol. Changing dose, adding a new product, or stopping the medication during this window obscures what finasteride alone is doing.

By the end of month 6, many clinical trials begin to detect statistically significant differences between finasteride and placebo on hair count and global photo grading. Visible improvement at the patient level is generally not yet clear, but it is approaching.

Months 6 to 9: Early regrowth signals

Months 6 to 9 are typically when the first visible signs of treatment response appear. The signals tend to be subtle at first:

• The crown looks slightly fuller in side-by-side photos.
• Existing hairs feel thicker or coarser than they did at baseline.
• Daily shed counts are noticeably lower than they were at month 3 or 4.
• The part line, hairline, or temples may show small but real density gains in photos.

What is generally not yet visible at this stage is dramatic regrowth in heavily miniaturized areas. The vertex (crown) tends to respond first and most reliably, which is consistent with what the original phase III trials showed in their photo-grading data. Hairline and temple recovery, when it occurs, generally lags behind crown recovery and is more limited in extent.

If you are tracking crown thinning specifically, this is the window where your monthly photos start to become genuinely informative.

Months 9 to 12: More apparent thickening

By month 9, hairs that started growing in months 2 to 4 have had enough time to reach a visible length and contribute to surface density. This is when patients most often describe a clear, mirror-visible improvement. It is also when family members and friends, who haven't been studying the scalp daily, may begin to comment.

The pivotal finasteride trials chose 12 months as a primary endpoint for good reason: the difference between finasteride and placebo at this point is consistent and clinically meaningful in most enrolled patients. In published photo-grading data:

• Around two-thirds of men show clear improvement at the vertex.
• A meaningful fraction show improvement at the hairline and mid-scalp.
• A smaller minority show no clear visible change despite ongoing treatment.

Importantly, even patients who do not see visible regrowth on photos at 12 months are generally showing stabilization, meaning they are not losing further ground compared to placebo. Stabilization is itself a clinically valuable outcome for a chronic, progressive condition.

For a broader look at what 12 months on hair-loss treatment can look like, our companion guide on what 12 months on hair-loss treatment looks like covers the visual side in more depth.

Year 1 to year 2: Results consolidate

Between month 12 and month 24, the biggest changes you will see are consolidation rather than continued dramatic improvement. The new anagen hairs that grew in during year 1 mature, gain pigmentation, and reach full thickness. The follicle population stabilizes. For patients who responded well in year 1, year 2 generally extends and locks in those gains.

The five-year follow-up data on finasteride is particularly useful here. Men who continued therapy through year 5 generally maintained the gains they had at year 1, while the placebo group continued to lose hair on a steady downward slope. This is the long-term value of the medication: not necessarily continued visible regrowth, but the prevention of the loss that would have occurred without it.

Some patients do see continued, gradual improvement in years 2 and beyond, particularly if they are also using minoxidil or other adjunctive treatments. Others reach a clear plateau by month 18 and remain stable from there.

For a sense of how this compares to other treatment timelines, How Long Does Hair Loss Treatment Take places finasteride alongside the broader treatment landscape.

What variability looks like in practice

The timeline above describes the average trajectory. In practice, individual patients diverge from it in predictable ways:

• Earlier-stage pattern hair loss generally responds faster and more visibly than advanced stages.
• Younger patients (in their 20s and early 30s) tend to show more regrowth than older patients, who tend to show more stabilization.
• Crown-predominant loss generally responds better than hairline-predominant loss.
• Combination therapy with minoxidil generally shows visible response slightly earlier than monotherapy.
• Patients with longstanding, fully miniaturized follicles may not regenerate those follicles regardless of treatment timeline; finasteride works on follicles that are still biologically viable.

These patterns are tendencies, not rules. The only way to know how your hair will respond to finasteride is to take it, track it consistently, and reassess at month 6 and 12 with your physician.

What happens if you stop along the way

It is worth understanding how the timeline reverses. Finasteride suppresses DHT only while it is being taken. If treatment is stopped, scalp DHT levels return to baseline within 1 to 2 weeks, and the underlying follicle miniaturization process resumes. Hair gained or maintained on therapy is generally lost over the following 6 to 12 months. This is covered in detail in What Happens If You Stop Treatment.

This is part of why the timeline is best understood as a sustained-treatment timeline. The benefits of finasteride accrue with continued use; they do not persist independently after discontinuation.

Considering medical assessment

If you are considering finasteride or are already on it and trying to make sense of your timeline, the right context is a clinical one. A physician can compare your photos to baseline objectively, examine the scalp, rule out compounding causes of shedding, and judge whether your trajectory is consistent with expected response. Setting expectations correctly at month 1 makes month 6 less anxious and month 12 more rewarding. A timeline is a guide; your individual response is what matters, and tracking it consistently with appropriate medical guidance is the most reliable way to know.